MKGAF (Merck KGaA) Long-Term Debt : $0 Mil (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Merck KGaA Long-Term Debt?

Merck KGaA's Long-Term Debt for the quarter that ended in Sep. 2024 was $0 Mil.

Merck KGaA's annual Long-Term Debt increased from Dec. 2021 ($8,958 Mil) to Dec. 2022 ($9,358 Mil) and increased from Dec. 2022 ($9,358 Mil) to Dec. 2023 ($9,647 Mil).

Merck KGaA Long-Term Debt Historical Data

The historical data trend for Merck KGaA's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Long-Term Debt Chart

Merck KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

9,032.22

11,457.42

8,958.19

9,358.05

9,646.67

Merck KGaA Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Debt	Get a 7-Day Free Trial															-	9,646.67	-	-	-

Merck KGaA (OTCPK:MKGAF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Merck KGaA Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKGAF) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

MKKGY:USA MRK1:Mexico 1MRK:Italy MRKd:UK 0O14:UK MRK:Germany MRK:Bulgaria

Address

Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website

https://www.emdgroup.com

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.